United States Biotechnology & Medical Research

Intellia Therapeutics Inc (NTLA)

Track

Track

Intellia Therapeutics experienced significant insider selling recently, with executives offloading shares worth over $670,000 in the last quarter. CEO John Leonard and CFO Edward Dulac led these divestments. This activity follows a 29.7% decline in stock value over ninety days, occurring ahead of the upcoming November earnings report.
Ticker: NTLA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Intellia Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
ELIANA CLARK Officer Officer
Transaction date
Proposed sale
Price
262.02
Quantity 42,402
Value US$4,367,110
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Planned sale
Price
174.33
Quantity 54,118 +0.4%
Value US$3,501,251
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Planned sale
Price
473.30
Quantity 85,922 -6.7%
Value US$1,125,367
2.4
LEONARD JOHN M Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.95
Quantity 22,675
Value US$293,641
3.9
Dulac Edward J III EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
11.25
Quantity 8,111 -5.2%
Value US$91,249
3.9
Dulac Edward J III EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.00
Quantity 4,677 -2.9%
Value US$84,186
3.9
EDWARD DULAC Officer Officer
Transaction date
Proposed sale
Price
17.24
Quantity 4,677
Value US$80,631
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
16.78
Quantity 2,641 -3.8%
Value US$44,316
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
13.78
Quantity 1,211 -0.8%
Value US$16,688
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Sale
Price
13.78
Quantity 607 -0.6%
Value US$8,364
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Sale
Price
9.21
Quantity 34,146 -3.3%
Value US$314,485
3.2
Schultes Birgit C EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
9.21
Quantity 8,508 -7.9%
Value US$78,359
3.9
Dulac Edward J III EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
9.21
Quantity 6,379 -6.0%
Value US$58,751
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
9.21
Quantity 9,515 -9.8%
Value US$87,633
3.3
Cohen Fred E Non-Executive Director
Transaction date
Purchase
Price
9.35
Quantity 150,000 +261.1%
Value US$1,402,500
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
9.21
Quantity 10,397 -9.3%
Value US$95,756
3.9
Lebwohl David EVP, Chief Medical Officer Officer
Transaction date
Planned sale
Price
9.21
Quantity 11,903 -8.9%
Value US$109,627
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
9.21
Quantity 2,989 -5.4%
Value US$27,529
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Planned sale
Price
9.59
Quantity 5,355 -0.5%
Value US$51,354
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Planned sale
Price
9.47
Quantity 32,832 -3.0%
Value US$310,919
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Planned sale
Price
9.49
Quantity 49,959 -4.4%
Value US$474,111
2.4
LEONARD JOHN M Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.33
Quantity 88,146
Value US$822,402
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
17.38
Quantity 1,871 -3.3%
Value US$32,518
3.2
Schultes Birgit C EVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
17.38
Quantity 31 -0.0%
Value US$539
3.2
CHASE WILLIAM J Non-Executive Director
Transaction date
Purchase
Price
10.03
Quantity 100,000 +288.2%
Value US$1,003,000
3.9
Dulac Edward J III EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
14.02
Quantity 7,462 -6.6%
Value US$104,617
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
9.95
Quantity 2,503 -4.2%
Value US$24,905
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
9.82
Quantity 1,022 -1.1%
Value US$10,036
GOODMAN JESSE Non-Executive Director
Transaction date
Planned sale
Price
9.23
Quantity 1,547 -6.0%
Value US$14,279
GOODMAN JESSE Non-Executive Director
Transaction date
Planned sale
Price
9.56
Quantity 1,547 -5.6%
Value US$14,789
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
8.50
Quantity 265 -1.4%
Value US$2,252
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Sale
Price
8.99
Quantity 679 -0.7%
Value US$6,104
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
8.99
Quantity 2,572 -2.2%
Value US$23,122
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
9.97
Quantity 265 -1.3%
Value US$2,642
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
12.18
Quantity 1,372 -2.9%
Value US$16,711
3.6
Hicks Derek EVP, Chief Business Officer Officer
Transaction date
Sale
Price
12.18
Quantity 6,502 -9.8%
Value US$79,194
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Sale
Price
12.18
Quantity 26,807 -2.8%
Value US$326,509
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
12.18
Quantity 7,074 -8.7%
Value US$86,161
3.9
Lebwohl David EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
12.18
Quantity 9,557 -9.8%
Value US$116,404
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
12.18
Quantity 8,966 -10.4%
Value US$109,206
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Sale
Price
12.18
Quantity 7,422 -10.4%
Value US$90,400
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
12.03
Quantity 556 -0.8%
Value US$6,689
3.6
Dube Michael P VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
19.01
Quantity 2,012 -4.1%
Value US$38,248
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
22.93
Quantity 405 -0.6%
Value US$9,287
Verwiel Frank Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 1,505 -7.7%
Value US$37,625
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
32.99
Quantity 2,297 -2.7%
Value US$75,778
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Sale
Price
32.99
Quantity 605 -0.8%
Value US$19,959
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
29.38
Quantity 667 -1.5%
Value US$19,596
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
28.66
Quantity 1,608 -3.5%
Value US$46,085
3.9
Sepp-Lorenzino Laura Officer Officer
Transaction date
Proposed sale
Price
28.18
Quantity 2,275
Value US$64,109
3.6
Goddard Glenn EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
29.46
Quantity 5,365 -11.7%
Value US$158,053
3.6
Hicks Derek EVP, Chief Business Officer Officer
Transaction date
Sale
Price
29.46
Quantity 3,877 -9.5%
Value US$114,216
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
29.46
Quantity 5,532 -10.7%
Value US$162,973
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Sale
Price
29.46
Quantity 19,223 -2.2%
Value US$566,310
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Sale
Price
29.46
Quantity 4,301 -9.5%
Value US$126,707
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
30.12
Quantity 307 -0.7%
Value US$9,247
3.9
Lebwohl David EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
29.46
Quantity 5,843 -9.7%
Value US$172,135
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
29.46
Quantity 3,805 -6.9%
Value US$112,095
3.6
John F. Crowley Former Director Non-Executive Director
Transaction date
Proposed sale
Price
15.45
Quantity 32,791
Value US$506,704
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
23.90
Quantity 265 -2.2%
Value US$6,334
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
42.33
Quantity 265 -2.1%
Value US$11,217
2.0
MUNA BHANJI Director Non-Executive Director
Transaction date
Proposed sale
Price
42.33
Quantity 265
Value US$11,217
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
39.30
Quantity 1,867 -13.0%
Value US$73,373
2.0
MUNA BHANJI Director Non-Executive Director
Transaction date
Proposed sale
Price
39.30
Quantity 1,867
Value US$73,378
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
40.51
Quantity 360 -0.8%
Value US$14,584
4.0
Clark Eliana EVP, Chief Technical Officer Officer
Transaction date
Planned sale
Price
45.00
Quantity 5,000 -10.0%
Value US$225,000
4.0
ELIANA CLARK Officer Officer
Transaction date
Proposed sale
Price
45.00
Quantity 5,000
Value US$225,000
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
43.88
Quantity 1,088 -1.9%
Value US$47,741
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
39.10
Quantity 689 -3.8%
Value US$26,940
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
38.22
Quantity 1,641 -8.2%
Value US$62,719
3.6
Hicks Derek EVP, Chief Business Officer Officer
Transaction date
Sale
Price
37.21
Quantity 1,812 -9.5%
Value US$67,425
3.9
Lebwohl David EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
37.21
Quantity 2,574 -9.1%
Value US$95,779
3.6
BASTA JAMES EVP, General Counsel Officer
Transaction date
Sale
Price
37.21
Quantity 1,138 -5.5%
Value US$42,345
2.4
LEONARD JOHN M President and CEO Executive Director
Transaction date
Sale
Price
37.21
Quantity 6,673 -0.9%
Value US$248,302
3.9
Sepp-Lorenzino Laura EVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
37.21
Quantity 2,508 -11.2%
Value US$93,323
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-05 2026-10-05 PrS Proposed sale
4.0
ELIANA CLARK

Officer

Officer
42,402
262.02
US$4,367,110 		42,402 262.02 US$4,367,110
2026-08-24 2026-08-21 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
54,118 +0.4%
174.33
US$3,501,251 		54,118 +0.4% 174.33 US$3,501,251
2026-08-24 2026-08-20 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
85,922 -6.7%
473.30
US$1,125,367 		85,922 -6.7% 473.30 US$1,125,367
2026-08-20 2026-08-20 PrS Proposed sale
2.4
LEONARD JOHN M

Officer; Director

Executive Director
22,675
12.95
US$293,641 		22,675 12.95 US$293,641
2026-07-24 2026-07-22 S Sale
3.9
Dulac Edward J III

EVP, Chief Financial Officer

Officer
8,111 -5.2%
11.25
US$91,249 		8,111 -5.2% 11.25 US$91,249
2026-07-06 2026-07-02 PlS Planned sale
3.9
Dulac Edward J III

EVP, Chief Financial Officer

Officer
4,677 -2.9%
18.00
US$84,186 		4,677 -2.9% 18.00 US$84,186
2026-07-02 2026-07-02 PrS Proposed sale
3.9
EDWARD DULAC

Officer

Officer
4,677
17.24
US$80,631 		4,677 17.24 US$80,631
2026-07-06 2026-07-01 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
2,641 -3.8%
16.78
US$44,316 		2,641 -3.8% 16.78 US$44,316
2026-03-03 2026-03-02 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
1,211 -0.8%
13.78
US$16,688 		1,211 -0.8% 13.78 US$16,688
2026-03-03 2026-03-02 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
607 -0.6%
13.78
US$8,364 		607 -0.6% 13.78 US$8,364
2026-01-07 2026-01-05 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
34,146 -3.3%
9.21
US$314,485 		34,146 -3.3% 9.21 US$314,485
2026-01-07 2026-01-05 PlS Planned sale
3.2
Schultes Birgit C

EVP, Chief Scientific Officer

Officer
8,508 -7.9%
9.21
US$78,359 		8,508 -7.9% 9.21 US$78,359
2026-01-07 2026-01-05 S Sale
3.9
Dulac Edward J III

EVP, Chief Financial Officer

Officer
6,379 -6.0%
9.21
US$58,751 		6,379 -6.0% 9.21 US$58,751
2026-01-07 2026-01-05 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
9,515 -9.8%
9.21
US$87,633 		9,515 -9.8% 9.21 US$87,633
2026-01-07 2026-01-05 B Purchase
3.3
Cohen Fred E
Non-Executive Director
150,000 +261.1%
9.35
US$1,402,500 		150,000 +261.1% 9.35 US$1,402,500
2026-01-07 2026-01-05 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
10,397 -9.3%
9.21
US$95,756 		10,397 -9.3% 9.21 US$95,756
2026-01-07 2026-01-05 PlS Planned sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
11,903 -8.9%
9.21
US$109,627 		11,903 -8.9% 9.21 US$109,627
2026-01-07 2026-01-05 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
2,989 -5.4%
9.21
US$27,529 		2,989 -5.4% 9.21 US$27,529
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
5,355 -0.5%
9.59
US$51,354 		5,355 -0.5% 9.59 US$51,354
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
32,832 -3.0%
9.47
US$310,919 		32,832 -3.0% 9.47 US$310,919
2025-12-12 2025-12-11 PlS Planned sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
49,959 -4.4%
9.49
US$474,111 		49,959 -4.4% 9.49 US$474,111
2025-12-11 2025-12-11 PrS Proposed sale
2.4
LEONARD JOHN M

Officer; Director

Executive Director
88,146
9.33
US$822,402 		88,146 9.33 US$822,402
2025-10-03 2025-10-01 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
1,871 -3.3%
17.38
US$32,518 		1,871 -3.3% 17.38 US$32,518
2025-10-03 2025-10-01 S Sale
3.2
Schultes Birgit C

EVP, Chief Scientific Officer

Officer
31 -0.0%
17.38
US$539 		31 -0.0% 17.38 US$539
2025-08-22 2025-08-20 B Purchase
3.2
CHASE WILLIAM J
Non-Executive Director
100,000 +288.2%
10.03
US$1,003,000 		100,000 +288.2% 10.03 US$1,003,000
2025-07-25 2025-07-23 S Sale
3.9
Dulac Edward J III

EVP, Chief Financial Officer

Officer
7,462 -6.6%
14.02
US$104,617 		7,462 -6.6% 14.02 US$104,617
2025-07-03 2025-07-02 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
2,503 -4.2%
9.95
US$24,905 		2,503 -4.2% 9.95 US$24,905
2025-07-03 2025-07-01 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
1,022 -1.1%
9.82
US$10,036 		1,022 -1.1% 9.82 US$10,036
2025-07-02 2025-07-01 PlS Planned sale
GOODMAN JESSE
Non-Executive Director
1,547 -6.0%
9.23
US$14,279 		1,547 -6.0% 9.23 US$14,279
2025-07-02 2025-06-30 PlS Planned sale
GOODMAN JESSE
Non-Executive Director
1,547 -5.6%
9.56
US$14,789 		1,547 -5.6% 9.56 US$14,789
2025-05-01 2025-04-29 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -1.4%
8.50
US$2,252 		265 -1.4% 8.50 US$2,252
2025-03-04 2025-03-04 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
679 -0.7%
8.99
US$6,104 		679 -0.7% 8.99 US$6,104
2025-03-04 2025-03-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
2,572 -2.2%
8.99
US$23,122 		2,572 -2.2% 8.99 US$23,122
2025-01-31 2025-01-29 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -1.3%
9.97
US$2,642 		265 -1.3% 9.97 US$2,642
2025-01-07 2025-01-03 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
1,372 -2.9%
12.18
US$16,711 		1,372 -2.9% 12.18 US$16,711
2025-01-07 2025-01-03 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
6,502 -9.8%
12.18
US$79,194 		6,502 -9.8% 12.18 US$79,194
2025-01-07 2025-01-03 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
26,807 -2.8%
12.18
US$326,509 		26,807 -2.8% 12.18 US$326,509
2025-01-07 2025-01-03 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
7,074 -8.7%
12.18
US$86,161 		7,074 -8.7% 12.18 US$86,161
2025-01-07 2025-01-03 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
9,557 -9.8%
12.18
US$116,404 		9,557 -9.8% 12.18 US$116,404
2025-01-07 2025-01-03 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
8,966 -10.4%
12.18
US$109,206 		8,966 -10.4% 12.18 US$109,206
2025-01-06 2025-01-03 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
7,422 -10.4%
12.18
US$90,400 		7,422 -10.4% 12.18 US$90,400
2025-01-06 2025-01-02 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
556 -0.8%
12.03
US$6,689 		556 -0.8% 12.03 US$6,689
2024-10-04 2024-10-02 S Sale
3.6
Dube Michael P

VP, Chief Accounting Officer

Officer
2,012 -4.1%
19.01
US$38,248 		2,012 -4.1% 19.01 US$38,248
2024-07-03 2024-07-01 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
405 -0.6%
22.93
US$9,287 		405 -0.6% 22.93 US$9,287
2024-06-20 2024-06-17 PlS Planned sale
Verwiel Frank
Non-Executive Director
1,505 -7.7%
25.00
US$37,625 		1,505 -7.7% 25.00 US$37,625
2024-03-05 2024-03-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
2,297 -2.7%
32.99
US$75,778 		2,297 -2.7% 32.99 US$75,778
2024-03-05 2024-03-04 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
605 -0.8%
32.99
US$19,959 		605 -0.8% 32.99 US$19,959
2024-01-10 2024-01-08 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
667 -1.5%
29.38
US$19,596 		667 -1.5% 29.38 US$19,596
2024-01-10 2024-01-08 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
1,608 -3.5%
28.66
US$46,085 		1,608 -3.5% 28.66 US$46,085
2024-01-08 2024-01-08 PrS Proposed sale
3.9
Sepp-Lorenzino Laura

Officer

Officer
2,275
28.18
US$64,109 		2,275 28.18 US$64,109
2024-01-05 2024-01-03 S Sale
3.6
Goddard Glenn

EVP, Chief Financial Officer

Officer
5,365 -11.7%
29.46
US$158,053 		5,365 -11.7% 29.46 US$158,053
2024-01-05 2024-01-03 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
3,877 -9.5%
29.46
US$114,216 		3,877 -9.5% 29.46 US$114,216
2024-01-05 2024-01-03 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
5,532 -10.7%
29.46
US$162,973 		5,532 -10.7% 29.46 US$162,973
2024-01-05 2024-01-03 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
19,223 -2.2%
29.46
US$566,310 		19,223 -2.2% 29.46 US$566,310
2024-01-05 2024-01-03 S Sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
4,301 -9.5%
29.46
US$126,707 		4,301 -9.5% 29.46 US$126,707
2024-01-05 2024-01-03 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
307 -0.7%
30.12
US$9,247 		307 -0.7% 30.12 US$9,247
2024-01-05 2024-01-03 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
5,843 -9.7%
29.46
US$172,135 		5,843 -9.7% 29.46 US$172,135
2024-01-05 2024-01-03 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
3,805 -6.9%
29.46
US$112,095 		3,805 -6.9% 29.46 US$112,095
2023-12-07 2023-12-06 PrS Proposed sale
3.6
John F. Crowley

Former Director

Non-Executive Director
32,791
15.45
US$506,704 		32,791 15.45 US$506,704
2023-11-02 2023-10-31 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -2.2%
23.90
US$6,334 		265 -2.2% 23.90 US$6,334
2023-08-02 2023-07-31 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
265 -2.1%
42.33
US$11,217 		265 -2.1% 42.33 US$11,217
2023-07-31 2023-07-31 PrS Proposed sale
2.0
MUNA BHANJI

Director

Non-Executive Director
265
42.33
US$11,217 		265 42.33 US$11,217
2023-07-10 2023-07-06 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
1,867 -13.0%
39.30
US$73,373 		1,867 -13.0% 39.30 US$73,373
2023-07-06 2023-07-06 PrS Proposed sale
2.0
MUNA BHANJI

Director

Non-Executive Director
1,867
39.30
US$73,378 		1,867 39.30 US$73,378
2023-07-06 2023-07-03 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
360 -0.8%
40.51
US$14,584 		360 -0.8% 40.51 US$14,584
2023-06-22 2023-06-20 PlS Planned sale
4.0
Clark Eliana

EVP, Chief Technical Officer

Officer
5,000 -10.0%
45.00
US$225,000 		5,000 -10.0% 45.00 US$225,000
2023-06-20 2023-06-20 PrS Proposed sale
4.0
ELIANA CLARK

Officer

Officer
5,000
45.00
US$225,000 		5,000 45.00 US$225,000
2023-03-03 2023-03-02 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
1,088 -1.9%
43.88
US$47,741 		1,088 -1.9% 43.88 US$47,741
2023-01-06 2023-01-05 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
689 -3.8%
39.10
US$26,940 		689 -3.8% 39.10 US$26,940
2023-01-06 2023-01-05 PlS Planned sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
1,641 -8.2%
38.22
US$62,719 		1,641 -8.2% 38.22 US$62,719
2023-01-06 2023-01-04 S Sale
3.6
Hicks Derek

EVP, Chief Business Officer

Officer
1,812 -9.5%
37.21
US$67,425 		1,812 -9.5% 37.21 US$67,425
2023-01-06 2023-01-04 S Sale
3.9
Lebwohl David

EVP, Chief Medical Officer

Officer
2,574 -9.1%
37.21
US$95,779 		2,574 -9.1% 37.21 US$95,779
2023-01-06 2023-01-04 S Sale
3.6
BASTA JAMES

EVP, General Counsel

Officer
1,138 -5.5%
37.21
US$42,345 		1,138 -5.5% 37.21 US$42,345
2023-01-06 2023-01-04 S Sale
2.4
LEONARD JOHN M

President and CEO

Executive Director
6,673 -0.9%
37.21
US$248,302 		6,673 -0.9% 37.21 US$248,302
2023-01-06 2023-01-04 S Sale
3.9
Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

Officer
2,508 -11.2%
37.21
US$93,323 		2,508 -11.2% 37.21 US$93,323
Explore more

More insider trading research around Intellia Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America